Quantum's HIMS Trading Guide 4/10/25

184
HIMS (Hims & Hers Health, Inc.) - Sector: Healthcare (Telehealth)

Sentiment: Bullish. Post-close call volume steady, RSI ~58 (up from ~55), Amplified GLP-1 demand—speculation persists despite tariff noise.

Tariff Impact: Minimal. Domestic focus shields HIMS; 104% China tariffs irrelevant unless generics supply tightens.

News/Catalysts:
Current: tariff pause softens market fear.

Upcoming: Retail Sales (April 15)—strong data could lift +5%; Fed rate outlook (May 2025)—cut signals might push +7%.

Technical Setup:
--Weekly Chart:
---HVN $30 (resistance), support ~$25.45.
---Uptrend (8-week EMA > 13-week > 48-week).
---RSI ~58, MACD above signal,
---Bollinger Bands upper band,
---Donchian Channels above midline,
---Williams %R -25.

--One-Hour Chart:
---Support $28.50, resistance $29.50.
---RSI ~60,
---MACD above signal,
---Bollinger Bands upper band,
---Donchian Channels above midline,
---Williams %R -20.

--10-Minute Chart:
---8/13/48 EMAs up,
---RSI ~62,
---MACD rising.

Options Data:
--GEX: Bullish—pinning near $29.
--DEX: Bullish—call delta dominates.
--IV: High—~50–55% vs. norm 45–50%.
--OI: Call-heavy—above $29.

Timeframe Analysis:
---Weekly: OI call-heavy (70% calls at $30), IV high (55%)—bullish, speculative push.
---Monthly: OI call-leaning (65% calls at $30–$32), IV moderate (50%)—bullish trend.
---3-Month: OI call-heavy (75% calls at $32), IV moderate (45%)—bullish long-term.

Directional Bias:
---Bullish. GEX/DEX and call OI signal strong upside; high IV fuels volatility—intraday breakout potential.

Sympathy Plays:
---TDOC rises with HIMS; AMWL gains with HIMS.
---Opposite: HIMS rallies → WMT fades.

Sector Positioning with RRG: Leading Quadrant (Healthcare vs. XLV)—growth persists.

Targets: Bullish +6% ($30.77); Bearish -3% ($28.16).

Penafian

Maklumat dan penerbitan adalah tidak dimaksudkan untuk menjadi, dan tidak membentuk, nasihat untuk kewangan, pelaburan, perdagangan dan jenis-jenis lain atau cadangan yang dibekalkan atau disahkan oleh TradingView. Baca dengan lebih lanjut di Terma Penggunaan.